miRNAs in non-alcoholic fatty liver disease

被引:28
|
作者
He, Zhen [1 ]
Hu, Cheng [1 ]
Jia, Weiping [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China
基金
中国国家自然科学基金;
关键词
nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; hepatocellular carcinoma; miRNA; HEPATIC LIPID-ACCUMULATION; DOWN-REGULATION; CIRCULATING MICRORNAS; LIPOPROTEIN-LIPASE; CHOLINE-DEFICIENT; UP-REGULATION; MOUSE MODEL; EXPRESSION; INHIBITION; METABOLISM;
D O I
10.1007/s11684-016-0468-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver cirrhosis and hepatocellular carcinoma and is a considerable threat to public health. miRNAs are important post-transcriptional regulators of gene expression, and the dysregulation of miRNAs is involved in various biological processes in the liver, including lipid homeostasis, inflammation, apoptosis, and cell proliferation. Recently, a number of studies have described the association between miRNAs and NAFLD progression and have shown that circulating miRNAs reflect histological changes in the liver. Therefore, circulating miRNAs have potential use for the evaluation of NAFLD severity. In this review, we discuss the involvement of miRNAs in NAFLD pathogenesis and the key role of miRNAs in the screening, diagnosis, and staging of NAFLD.
引用
收藏
页码:389 / 396
页数:8
相关论文
共 50 条
  • [1] miRNAs in non-alcoholic fatty liver disease
    Zhen He
    Cheng Hu
    Weiping Jia
    [J]. Frontiers of Medicine, 2016, 10 : 389 - 396
  • [2] miRNAs in non-alcoholic fatty liver disease
    Zhen He
    Cheng Hu
    Weiping Jia
    [J]. Frontiers of Medicine, 2016, 10 (04) : 389 - 396
  • [3] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [4] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [5] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    [J]. LANCET, 2021, 397 (10290): : 2212 - 2224
  • [6] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    [J]. CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [7] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    [J]. BMC MEDICINE, 2017, 15
  • [8] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [9] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [10] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    [J]. JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280